Institutional Fund
Fairmount Funds Management LLC
West Conshohocken, PACIK 18025285 filings on record
Portfolio Value
$1.38B
Q1 2026
Holdings
12
Reported positions
New Buys
1
Opened this quarter
QoQ Change
+5.4%
from $1.31B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Galecto Inc16.3%
- Dianthus Therapeutics Inc15.4%
- Cogent Biosciences Inc15.3%
- Spyre Therapeutics Inc14.6%
- Oruka Therapeutics Inc13.1%
- Viridian Therapeutics Inc5.5%
- Other19.7%
Portfolio Holdings
12 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Galecto Inc | 8.71M | $225.67M | 16.3% | +8.71M | New |
| 2 | Dianthus Therapeutics Inc | 2.54M | $212.92M | 15.4% | +400.0K | Added |
| 3 | Cogent Biosciences Inc | 5.50M | $211.83M | 15.3% | −3.50M | Reduced |
| 4 | Spyre Therapeutics Inc | 4.02M | $202.67M | 14.6% | 0 | Held |
| 5 | Oruka Therapeutics Inc | 3.71M | $181.74M | 13.1% | 0 | Held |
| 6 | Viridian Therapeutics Inc | 3.91M | $76.57M | 5.5% | 0 | Held |
| 7 | Enliven Therapeutics Inc | 1.86M | $72.74M | 5.3% | −1.86M | Reduced |
| 8 | Jade Biosciences Inc | 4.55M | $63.98M | 4.6% | 0 | Held |
| 9 | Crescent Biopharma Inc. | 2.75M | $50.48M | 3.6% | 0 | Held |
| 10 | Zenas Biopharma Inc | 2.36M | $46.12M | 3.3% | +150.0K | Added |
2 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio